跳至主要内容
临床试验/JPRN-UMIN000000495
JPRN-UMIN000000495未知未知

Clinical study on anti-atherosclerotic effect of azelnidipine/amlodipine in the hypertensive patients with type 2 diabetes - Anti-atherosclerotic effect of long-acting calcium channel blockers in diabetes

Advanced Medicine Study Group in Kyushu Island0 个研究点目标入组 150 人开始时间: 2007年1月1日最近更新:
适应症

试验速览

阶段
未知
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Patients using insulin 2. Patients with secondary hypertension 3. Patients on hemodialysis 4. Pregnant women or those who plan pregnancy 5. Patients with history of hypersensitivity to olmesartan, azelnizipine, amlodipine 6. Patients with severe liver injury 7. Patients with severe renal failure (serum CRE>=3.0mg/dl) 8. Other patients judged unsuitable for the study by investigator

研究者

发起方
Advanced Medicine Study Group in Kyushu Island

相似试验